MedTrace Logo

Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation

NCT06791629 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2025-01-24

No results posted yet for this study

Summary

This clinical trial aims to compare the efficacy and safety of pulsed field ablation and radiofrequency ablation to treat persistent atrial fibrillation in adults.

Participants will:

Undergo pulsed field ablation or radiofrequency ablation. Keep follow-up for at least 12 months.

Conditions

  • Persistent Atrial Fibrillation
  • Radiofrequency Catheter Ablation
  • Pulsed Field Ablation

Interventions

DEVICE

Pulsed Field Ablation

Patients will be treated with pulsed field ablation for atrial fibrillation.

DEVICE

Radiofrequency Ablation

Patients will be treated with radiofrequency ablation for atrial fibrillation.

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-15
Primary Completion
2026-12-15
Completion
2027-02-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06791629 on ClinicalTrials.gov